Cart
sales@molnova.com
2-Isopropyl Thioxanthone
CAS No. 5495-84-1
2-Isopropyl Thioxanthone( —— )
Catalog No. M21290 CAS No. 5495-84-1
2-Isopropyl Thioxanthone has potential anti-estrogenic and anti-androgenic properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 34 | In Stock |
|
| 500MG | 55 | In Stock |
|
| 1G | 83 | In Stock |
|
Biological Information
-
Product Name2-Isopropyl Thioxanthone
-
NoteResearch use only, not for human use.
-
Brief Description2-Isopropyl Thioxanthone has potential anti-estrogenic and anti-androgenic properties.
-
Description2-Isopropyl Thioxanthone has potential anti-estrogenic and anti-androgenic properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5495-84-1
-
Formula Weight254.3
-
Molecular FormulaC16H14OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)c(cc1)cc2c1Sc(cccc1)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peijnenburg A Riethof-Poortman J Baykus H et al. AhR-agonistic anti-androgenic and anti-estrogenic potencies of 2-isopropylthioxanthone (ITX) as determined by in vitro bioassays and gene expression profiling[J]. Toxicology in Vitro 2010 24(6):0-1628.
molnova catalog
related products
-
Tryptophol
Tryptophol is a metabolite formed in the liver after disulfiram treatment that induces sleep in humans. It is also a secondary product of alcoholic fermentation.
-
CFM 4
CFM 4 is a potent small molecule CARP-1/APC-2 antagonist that prevents CARP-1 from binding to APC-2, contributes to G2M cell cycle arrest, and induces apoptosis, with an IC50 in the range of 10-15 μM.
-
HA15
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
